Why Cronos Group (TSX:CRON) Declined Despite Posting a Huge Profit in Q1

Cronos Group Inc  (TSX:CRON)(NASDAQ:CRON) released its quarterly results last week, which showed sales more than doubling from the previous year. The company also recorded a massive $428 million profit during the quarter as well. However, the stock still declined 7% last week, leaving some investors scratching their heads. Why is the stock down? Although Cronos saw a big increase in…

Read More

Why Did Cronos Group (TSX:CRON) Stock Trade 9% Lower After Q1 Earnings on Thursday?

Cannabis producer Cronos Group (TSX:CRON)(NASDAQ:CRON) shares traded as low as 9.6% on Thursday after the cash-rich company released a mixed bag of Q1 2019 results before market open. The company actually showed some improvements in its financial performance as compared to a previous quarter, but revenue growth, the market’s main focus today, was much weaker than desirable. Not-so-impressive revenue growth…

Read More

2 Marijuana Stocks to Watch in May

The battle for supremacy in the marijuana industry is intensifying. While Canopy Growth and Aurora Cannabis have managed to capture about 50% of the Canadian market, other pot companies are attempting to improve their positions. Some firms are successful at doing so, and others, not so much. Let’s look at two marijuana companies to watch this coming May: Hexo (TSX:HEXO) and…

Read More

2 Pot Stocks That Are up Over 50% Year to Date (And 1 That’s Struggling!)

It’s been an interesting year for pot stocks, as we saw a big sell-off happen after legalization in October and then a strong recovery early on in 2019. Below, I’ll look at two stocks that have done very well lately and one that’s struggled that might be an option for investors to buy on the dip. Cronos Group (TSX:CRON)(NASDAQ:CRON) has…

Read More

Marijuana Stocks: Is Cronos Group Inc. (TSX:CRON) a Buy?

It’s not too convincing to stay loyal to Cronos Group (TSX:CRON)(NASDAQ:CRON) stock after seeing its fourth-quarter earnings report. The marijuana producer has delivered sales much lower than market expectations, raising questions about its rich valuations. In a report released on March 26, Cronos reported that sales for the quarter, the first full period after Canada legalized recreational consumption, were $5.6…

Read More

Cannabis Stocks: 3 Things to Know Before Buying

Recent market action has shown that at least some cannabis stocks may be taking a breather. And while past performance in certainly exceptional, we need to focus on what we can expect for future performance. Canopy Growth (TSX:WEED)(NYSE:CGC) stock is down 6% in the last month and Cronos Group (TSX:CRON)(NASDAQ:CRON) stock is down 21%. Let’s look at three things you…

Read More

Is Cronos Group Inc. (TSX:CRON) a Buy After Earnings?

Cronos Group (TSX:CRON)(NASDAQ:CRON) recently reported its much-anticipated fourth-quarter earnings report. The legalization of recreational marijuana happened in the midst of the company’s Q4 operations, and Cronos has been one of the best-performing pot stocks since the beginning of the year. Needless to say, expectations were high, but Cronos fell short of those expectations. Revenues soar. So do net losses On…

Read More

What Cronos Group Inc.’s (TSX:CRON) Earnings Mean for Cannabis Stocks

If you’ve been plugging your ears against the noise that is the cannabis industry this week, then you may not have heard about the latest fourth-quarter earnings report getting analysts going. Cronos Group Inc.  (TSX:CRON)(NASDAQ:CRON) announced a net loss on March 26, due to an increase in operating costs, missing analysts’ estimates. The loss wasn’t small either, with the company…

Read More

5 Takeaways From Cronos Group’s (TSX:CRON) Latest Quarterly Results

Canadian marijuana firm Cronos Group (TSX:CRON)(NASDAQ:CRON) released seemingly weak and unimpressive fourth-quarter and full-year 2018 financial results on Tuesday that exhibited non-disclosure of some information of interest and poor operating performance. A quarterly net revenue of $5.6 million represented a sequential revenue growth of just 49% from prior-quarter reading, while the competition did much better, even as average prices fell…

Read More